| Identification | Back Directory | [Name]
N-(1-Morpholin-4-ylpropan-2-yl)-6-(8-pyridin-4-ylimidazo[4,5-c][1,7]naphthyridin-1-yl)quinolin-2-amine | [CAS]
1984784-12-4 | [Synonyms]
N-(1-Morpholin-4-ylpropan-2-yl)-6-(8-pyridin-4-ylimidazo[4,5-c][1,7]naphthyridin-1-yl)quinolin-2-amine
N-[(2R)-1-Morpholin-4-ylpropan-2-yl]-6-(8-pyridin-4-ylimidazo[4,5-c][1,7]naphthyridin-1-yl)quinolin-2-amine
2-Quinolinamine, N-[(1R)-1-methyl-2-(4-morpholinyl)ethyl]-6-[8-(4-pyridinyl)-1H-imidazo[4,5-c][1,7]naphthyridin-1-yl]- | [Molecular Formula]
C30H28N8O | [MOL File]
1984784-12-4.mol | [Molecular Weight]
516.6 |
| Hazard Information | Back Directory | [Uses]
Cot inhibitor-3 (Compound 33) is a potent and selective cancer osaka thyroid (COT) kinase inhibitor, with an IC50 of 4 nM. Cot inhibitor-3 can be used to prevent inflammation-driven lameness[1]. | [References]
[1] Glatthar R, et, al. Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors. J Med Chem. 2016 Aug 25;59(16):7544-60. DOI:10.1021/acs.jmedchem.6b00598 |
|
|